SCHEMBL3307322

SCHEMBL3307322

CC(=O)/C(C)=C\C1=C(C)CCCC1(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.57
RARA P10276 7/20 0.49
RARB P10826 7/20 0.49
RARG P13631 7/20 0.49
HAO1 Q9UJM8 1/20 0.49
ALDH1A1 P00352 8/20 0.48
RXRA P19793 7/20 0.48
MAPT P10636 5/20 0.48
CYP3A4 P08684 5/20 0.48
PTGS1 P23219 4/20 0.48
RXRB P28702 3/20 0.48
RXRG P48443 3/20 0.48
RORC P51449 2/20 0.48
ADORA3 P0DMS8 2/20 0.48
MAPK1 P28482 2/20 0.48
HTR2B P41595 2/20 0.48
BLM P54132 2/20 0.48
HIF1A Q16665 2/20 0.48
DRD3 P35462 2/20 0.48
LMNA P02545 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1472109 1.00 CYP1A2 (0.57) CYP1A2RARARARBRARGHAO1
SCHEMBL1472108 1.00 CYP1A2 (0.57) CYP1A2RARARARBRARGHAO1
SCHEMBL5435696 0.91 CYP1A2 (0.51) CYP1A2RARARARBRARGHAO1
SCHEMBL5435690 0.91 CYP1A2 (0.51) CYP1A2RARARARBRARGHAO1
SCHEMBL8474784 0.84 CYP1A2 (0.55) CYP1A2RARARARBRARGHAO1
SCHEMBL30358271 0.84 CYP1A2 (0.51) CYP1A2RARARARBRARGHAO1
SCHEMBL13908096 0.81 CYP1A2 (0.41) CYP1A2RARARARBRARGHAO1
SCHEMBL14430255 0.81 CYP1A2 (0.51) CYP1A2RARARARBRARGHAO1
SCHEMBL5432781 0.79 ALDH1A1 (0.56) CYP1A2RARARARBRARGALDH1A1
SCHEMBL5437068 0.79 ALDH1A1 (0.58) CYP1A2RARARARBRARGHAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120202281-A Substituted 1, 3-dioxolan-4-ones and 1, 3-dioxane-4-ones as perfume ingredients 巴斯夫欧洲公司 2025-06-24 CN claimed
EP-4356894-A1 SUSTAINABLE PRODUCT WITH MALODORS Beiersdorf AG (DE) 2024-04-24 EP claimed
CN-117396586-A 1, 4-butanediol mono-or diesters as fragrance chemicals 巴斯夫欧洲公司 2024-01-12 CN claimed
EP-4257663-A1 FOOD CONTACT SURFACE SANITIZING LIQUID The Procter & Gamble Company (US) 2023-10-11 EP claimed
CN-113116738-B External additive, application thereof and skin external product 新生活化妆品科技(上海)有限公司 2022-09-02 CN claimed
US-12552732-B2 Cyclopropanated sandalwood type compounds SYMRISE AG (DE) 2026-02-17 US disclosed
US-12492356-B2 Oxa-sandalwood-type fragrance compounds SYMRISE AG (DE) 2025-12-09 US disclosed
US-12441953-B2 Isomer mixtures of unsaturated macrocyclic musk compounds SYMRISE AG (DE) 2025-10-14 US disclosed
US-12421480-B2 Core-shell capsules prepared with linear and cyclic aliphatic polyisocyanates SYMRISE AG (DE) 2025-09-23 US disclosed
US-20250281661-A1 EMULSIONS FOR USE IN AIR FRESHENERS DEVICES SYMRISE AG (DE) 2025-09-11 US disclosed
US-12410113-B2 Sandalwood-type fragrance compounds SYMRISE AG (DE) 2025-09-09 US disclosed
EP-3898910-B1 ALICYCLIC MUSK FRAGRANCE COMPOUNDS SYMRISE AG (DE) 2025-09-03 EP disclosed
EP-3197509-A1 METHOD OF MAKING PERFUMED GOODS THE PROCTER & GAMBLE COMPANY (US) 2017-08-02 EP disclosed
CN-106999972-A System and method for discharging fragrance 阿甘芳香和精细化工有限公司 2017-08-01 CN disclosed
CN-106999973-A System and method for discharging edible material 阿甘芳香和精细化工有限公司 2017-08-01 CN disclosed
US-20160306909-A1 METHOD OF MAKING PERFUMED GOODS PROCTER & GAMBLE (US) 2016-10-20 US disclosed
US-20160092661-A1 METHOD OF MAKING PERFUMED GOODS THE PROCTER & GAMBLE COMPANY 2016-03-31 US disclosed
WO-2016049393-A1 METHOD OF MAKING PERFUMED GOODS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO disclosed
US-20100248390-A1 COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS DUKE UNIVERSITY (US) 2010-09-30 US disclosed
US-20100111889-A1 Malodor Control System PROCTER & GAMBLE COMPANY, THE 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12410113-B2 Sandalwood-type fragrance compounds FDFT1, FAAH2, FAAH CYP1A2 230/4885RARA 3672/4885RARB 3041/4885
US-12552732-B2 Cyclopropanated sandalwood type compounds FAAH2, ADCY10, OR10J3 CYP1A2 303/4885RARA 3846/4885RARB 3500/4885
US-12492356-B2 Oxa-sandalwood-type fragrance compounds FDFT1, FAAH2, ALDH1A1 CYP1A2 378/4885RARA 4469/4885RARB 3833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.